Balasabas, Crislie T.
HRN: 20-76-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2024
CEFUROXIME 1.5GM (VIAL)
11/04/2024
11/11/2024
IV
1.5gram
Q8H
S/P Superficial Parotidectomy
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes